top of page


Clinical trials and basic clinical science research

In the past 30 years MARC has been involved in over 200 pharmaceutical trials involving around 30 different pharmaceutical companies. We were involved in the first cholinesterase inhibitor trials and first amyloid antibody studies. We have extensive experience of antibody and new generation anti-inflammatory agents.  MARC also has close ties to the University of Southampton and has generated around 300 scientific papers in dementia research.

bottom of page